In Situ Peptide Self-Assembly Augments Antibody Recruitment for Tumor Immunotherapy

Journal:

Advanced Materials

Published:

2026-04-14

DOI:

10.1002/adma.202521379

Affiliations:

4

Authors:

8

Go to article

Institutions	Authors	Share
Harbin Medical University Cancer Hospital, China	3.500000	0.44
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, China	2.500000	0.31
University of Chinese Academy of Sciences (UCAS), China	1.500000	0.19
Harbin Medical University (HMU), China	0.500000	0.06

Interested in Immunology?